The price of medical drugs in Switzerland remains higher than in other major European markets, especially for generic drugs, which are almost twice as expensive. Patented drugs also cost more.
The reason for the increased price difference for patent-protected medicines is the exchange rate, said Santésuisse and Interpharma, umbrella organisations for Swiss insurers and pharmaceutical research companies, on Thursday.
At an exchange rate of CHF1.11 per euro, the 250 top-selling patented drugs were 6.9% more expensive in Switzerland in spring 2021 than in comparable foreign countries. A year ago the same medicines were only 4.5% more expensive.
The price difference for 250 patent-expired original drugs also increased, to 11.5% from 10% in 2020. However, the price difference remains by far the greatest for generics. On average, these cost 45% more in Switzerland, compared with 42% more in the previous year.
“Unfortunately the premium payers felt the increased price differences […] very directly: in Switzerland we pay over CHF200 million ($222 million) more for patent-protected medicines than in the comparable countries,” said Verena Nold, director of Santésuisse, in a statementExternal link.
Reference price system
Nold is therefore once again calling for the reference price system, which establishes a common reimbursement level or reference price for a group of interchangeable medicines. This could save the local premium payers several hundred million francs a year, she said.
“Parliament still has time this year to show its colours and stand up for the premium payers,” she said.
The price comparison was carried out for the 12th time. It compared the ex-factory prices in Switzerland with those in Belgium, Denmark, Germany, Finland, France, the United Kingdom, the Netherlands, Austria and Sweden for patented and off-patent medicines and generics.
Popular Stories
More
Swiss Abroad
How centuries of Swiss emigrants left their mark on the US
Bodycams: essential for good law enforcement, or a privacy risk?
Did you ever come across bodycams in your place of residence and if so, how do you think the use of bodycams alter the relationship between the public and (transport) police?
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Zurich cannabis study receives positive assessment
This content was published on
Health officials in the city of Zurich have given a positive assessment of a controlled study into the recreational use of cannabis, one year after it was launched.
This content was published on
Electricity prices will fall by an average of 10% for Swiss households in 2025, the Federal Electricity Commission ElCom reported on Thursday.
‘Inclusion initiative’ submitted to Swiss Federal Chancellery
This content was published on
Civil society groups handed in 108,000 signatures for their "inclusion initiative" to the Federal Chancellery in Bern on Thursday.
Expert group proposes CHF4-5bn of cuts to Swiss federal budget
This content was published on
A Swiss government-appointed group of experts has proposed a series of over 60 measures to help get federal finances get out of the red and save CHF4-5 billion a year.
Saas Valley in southern Switzerland remains isolated after landslide
This content was published on
Storms and heavy rain have triggered a landslide that closed the main cantonal road into the Saas Valley in southern Switzerland on Thursday.
Swiss prosecutor demands 14-year prison sentence for Sperisen
This content was published on
A Swiss prosecutor has demanded a 14-year sentence against Erwin Sperisen, former head of the Guatemalan National Civil Police.
This content was published on
Logitech International co-founder Daniel Borel's attempt to oust Wendy Becker, chair of the board of directors, has once again failed.
This content was published on
The storms in June and July caused damages estimated at CHF125 million ($147 million) for canton Valais in southern Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Drug prices fall in Switzerland but generics remain expensive
This content was published on
Switzerland is narrowing the gap with other European countries when it comes to the cost of medicines. But generics are still double the price.
Costs of generic drugs and outpatient services targeted
This content was published on
The government wants to cap prices for generic drugs as part of a package of measures to reduce rising health costs in Switzerland.
This content was published on
Switzerland could save millions of francs by prescribing low-priced biotech drug copies, known as biosimilars, instead of expensive biologicals.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.